Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0001209191-15-015629
Filing Date
2015-02-18
Accepted
2015-02-18 19:39:40
Documents
2
Period of Report
2015-02-17

Document Format Files

Seq Description Document Type Size
1 FORM 3/A SUBMISSION doc3a.html 3/A  
1 FORM 3/A SUBMISSION doc3a.xml 3/A 2741
2 EX-24 DOCUMENT attachment1.htm EX-24 4543
  Complete submission text file 0001209191-15-015629.txt   8701
Mailing Address 131 HARTWELL AVE 1ST FLOOR, SUITE 105 LEXINGTON MA 02421
Business Address 131 HARTWELL AVE 1ST FLOOR, SUITE 105 LEXINGTON MA 02421 781-676-2100
INOTEK PHARMACEUTICALS CORP (Issuer) CIK: 0001281895 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O MEDIMMUNE VENTURES, INC. ONE MEDIMMUNE WAY GAITHERSBURG MD 20878
Business Address
Peimer Isai (Reporting) CIK: 0001572461 (see all company filings)

Type: 3/A | Act: 34 | File No.: 001-36829 | Film No.: 15629786